trial

Therapeutic Effect of Quetiapine on Methamphetamine-Induced Psychosis

NCTId NCT01939093
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 80 (actual)
Sponsored by Chulalongkorn University
Primary completion 2011-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
80 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2010-03
Primary completion
2011-09
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
DiazepamVitamin B1-6-12Stugeron

Sponsors

Chulalongkorn UniversityLead Sponsor
Thanyarak InstituteCollaborator
National Research Council of ThailandCollaborator

Investigators

1
Viroj Verachai, M.D.Principal Investigator

Sites

1 total
Pathum Thani, Thailand

Facts & assertions

4 sourced
Enrollment
80
Phase
PHASE4
Primary Completion Date
2011-09
Status
COMPLETED
relationships
The graph out of here
drug
Diazepam
drug
Vitamin B1-6-12
drug
Stugeron
drug
lead_sponsor
Chulalongkorn University
company
collaborator
Thanyarak Institute
company
National Research Council of Thailand
company
indication
Methamphetamine-induced Psychosis
indication
Psychotic Disorders
indication
investigator
Viroj Verachai, M.D.
person